• Emir U. E., Clark H. B., Vollmers M. L., Eberly L. E. and Öz G. (2013) Non-invasive detection of neurochemical changes prior to overt pathology in a mouse model of spinocerebellar ataxia type 1. J. Neurochem. doi:10.1111/jnc.12435.
  • Guerrini L., Lolli F., Ginestroni A. et al. (2004) Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain 127, 17851795.
  • Lirng J. F., Wang P. S., Chen H. C., Soong B. W., Guo W. Y., Wu H. M. and Chang C. Y. (2012) Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS ONE 7, e47925.
  • Öz G., Hutter D., Tkáč I., Clark H. B., Gross M. D., Jiang H., Eberly L. E., Bushara K. O. and Gomez C. M. (2010a) Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status. Mov. Disord. 25, 12531261.
  • Öz G., Nelson C. D., Koski D. M. et al. (2010b) Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1. J. Neurosci. 30, 38313838.
  • Öz G., Vollmers M. L., Nelson C. D., Shanley R., Eberly L. E., Orr H. T. and Clark H. B. (2011) In vivo monitoring of recovery from neurodegeneration in conditional transgenic SCA1 mice. Exp. Neurol. 232, 290298.